Quantitative Proton Nuclear Magnetic Resonance evaluation and total assignment of the capsular polysaccharide Neisseria meningitidis serogroup X

Journal of Pharmaceutical and Biomedical Analysis

Volumn 70, Issue , 2012, Pages 295-300

  Garrido, Raine ^a   Puyada, Alain ^a   Fernández, Anaís ^a   González, Majela ^a   Ramírez, Ubel ^b   Cardoso, Felix ^a   Valdés, Yury ^a   González, Domingo ^b   Fernández, Violeta ^a,b   Vérez, Vicente ^a   Vélez, Hermán ^a  

^a Center of Biomolecular Chemistry   (Cuba)

^b FINLAY INSTITUTE   (Cuba)

Author keywords

Assignment; Neisseria meningitidis; NMR; Quantitative analysis; X serogroup

Indexed keywords

BACTERIAL POLYSACCHARIDE;

ACCURACY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COLORIMETRY; NEISSERIA MENINGITIDIS; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STRUCTURE ANALYSIS;

BACTERIAL CAPSULES; CARBOHYDRATE CONFORMATION; CARBON ISOTOPES; LINEAR MODELS; MOLECULAR STRUCTURE; NEISSERIA MENINGITIDIS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHORUS ISOTOPES; POLYSACCHARIDES, BACTERIAL; PROTONS; REPRODUCIBILITY OF RESULTS;

EID: 84866262070     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.07.014     Document Type: Article

References (21)

1. Stephens D.S. Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis. Vaccine 2009, 27:71-78.
2. Bories S., Slaterus K.W., Faucon R., Audiffren P., Vandekerkove M. Peut-on individualiser deux nouveaux groupes sérologiques de Neisseria meningitidis?. Med. Trop. 1966, 26:603-616.
3. Gagneux S.P., Hodgson A., Smith T.A., Wirth T., Ehrhard I., Morelli G., Genton B., Binka F.N., Achtman M., Pluschke G. Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. J. Infect. Dis. 2002, 185:618-626.
4. Nicolas P., Boisier P., Djibo S., Taha M.-K., Jeanne I., Maïnassara H.B., Tenebray B., Kairo K.K., Giorgini D., Chanteau S. Meningococcal meningitis: Unprecedented Incidence of Serogroup X-related Cases in 2006 in Niger. Clin. Infect. Dis. 2007, 44:657-663.
5. Mutonga D.M., Pimentel G., Muindi J., Nzioka C., Mutiso J., Klena J.D., Morcos M., Ogaro T., Materu S., Tetteh C., Messonnier N.E., Breiman R.F., Feikin D.R. Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya. Am J Trop Med Hyg. 2009, 80:619-624.
6. Joshi V.S., Bajaj I.B., Survase S.A., Singhal R.S., Kennedy J.F. Meningococcal polysaccharide vaccines: a review. Carbohydr. Polym. 2009, 75:553-565.
7. Bundle D.R., Smith I.A., Jennings H.J. Determination of the structure and conformation of bacterial polysaccharides by carbon 13 nuclear magnetic resonance. J. Biol. Chem. 1974, 249:2275-2281.
8. Jacobsen N.E. NMR Spectroscopy Explained: Simplified Theory, Applications and Examples for Organic Chemistry and Structural Biology 2007, John Wiley & Sons, Hoboken, NJ.
9. Jones C. NMR assays for carbohydrate-based vaccines. J. Pharm. Biomed. Anal. 2005, 38:840-850.
10. 1H NMR: development and potential of a method for natural products analysis. J. Nat. Prod. 2005, 68:133-149.
11. 1H NMR spectroscopy. Trends Anal. Chem. 2012, 35:5-26.
12. Chen P.S., Toribara T.Y., Warner H. Microdetermination of phosphorus. Anal. Chem. 1956, 28:1756-1758.
13. Braun S., Kalinowski H.-O., Berger S. 200 and More Basic NMR Experiments 2004, Wiley-VCH, Weinheim.
14. Ernst R.R., Anderson W.A. Application of Fourier transform spectroscopy to magnetic resonance. Rev. Sci. Instrum. 1966, 37:93-101.
15. ICH Guideline Q2R1, Validation of Analytical Procedures: Text and Methodology, Geneva, Switzerland, 2005, p. 13.
16. Zhong B., Qiu C., Tang D. Encyclopedia of Biopharmaceutical Statistics 2003, 1-14. Marcel Dekker, New York. C. Shein-Chung (Ed.).
17. Bubb W.A. NMR spectroscopy in the study of carbohydrates: characterizing the structural complexity. Concepts Magn. Reson. 2003, 19A:1-19.
18. Beyer T., Diehl B., Holzgrabe U. Quantitative NMR spectroscopy of biologically active substances and excipients. Bioanal. Rev. 2010, 2:1-22.
19. Xu Q., Kless J., Teyral J., Capen R., Huang M., Sturgess A.W., Hennessey J.P., Washabaugh M., Sitrin R., Abeygunawardana Ch Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type b polysaccharide intermediate for PedvaxHIB. Anal. Biochem. 2005, 337:235-245.
20. Schofield T.L. Encyclopedia of Biopharmaceutical Statistics 2003, 63-71. Marcel Dekker, New York. C. Shein-Chung (Ed.).
21. Diehl B., Malz F., Holzgrabe U. Quantitative NMR spectroscopy in the quality evaluation of active pharmaceutical ingredients and excipients. Spectrosc. Eur. 2007, 19:15-19.